UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

Journal of Virology, 2001-04, Vol.75 (8), p.4002-4007

2001

Volltextzugriff (PDF)

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates

Vaccine, 1999-04, Vol.17 (15), p.1869-1882

1999

Volltextzugriff (PDF)

Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA

The Journal of infectious diseases, 1995-05, Vol.171 (5), p.1144-1151

1995

Volltextzugriff (PDF)

Antigenic Relationships between Flaviviruses as Determined by Cross-neutralization Tests with Polyclonal Antisera

Journal of general virology, 1989-01, Vol.70 (1), p.37-43

1989

Volltextzugriff (PDF)

Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America

The American journal of tropical medicine and hygiene, 1999-10, Vol.61 (4), p.579-586

1999

Volltextzugriff (PDF)

Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever

The American journal of tropical medicine and hygiene, 1994-04, Vol.50 (4), p.452-459

1994

Volltextzugriff (PDF)

Recurrence of Rift Valley fever in Egypt

The Lancet (British edition), 1993-11, Vol.342 (8880), p.1149-1150

1993

Volltextzugriff (PDF)

Jatobal virus is a reassortant containing the small RNA of Oropouche virus

Virus research, 2001-09, Vol.77 (1), p.25-30

2001

Volltextzugriff (PDF)

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

Vaccine, 1999-05, Vol.17 (18), p.2259-2264

1999

Volltextzugriff (PDF)

Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains

The American journal of tropical medicine and hygiene, 2001-07, Vol.65 (1), p.64-69

2001

Volltextzugriff (PDF)

Trocara virus: a newly recognized Alphavirus (Togaviridae) isolated from mosquitoes in the Amazon Basin

The American journal of tropical medicine and hygiene, 2001-01, Vol.64 (1-2), p.93-97

2001

Volltextzugriff (PDF)

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial

The American journal of tropical medicine and hygiene, 2002-05, Vol.66 (5), p.533-541

2002

Volltextzugriff (PDF)

Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature

Archives of virology, 2002-12, Vol.147 (12), p.2465-2471

2002

Volltextzugriff (PDF)

Mayaro virus fever in French Guiana: isolation, identification, and seroprevalence

The American journal of tropical medicine and hygiene, 1998-09, Vol.59 (3), p.452-456

1998

Volltextzugriff (PDF)

Mice immunized with a subviral particle containing the japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

Virology (New York, N.Y.), 1992-06, Vol.188 (2), p.714-720

1992

Volltextzugriff (PDF)

Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice

Vaccine, 1994, Vol.12 (3), p.279-285

1994

Volltextzugriff (PDF)

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

Virology (New York, N.Y.), 1991, Vol.180 (1), p.294-305

1991

Volltextzugriff (PDF)

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates

Vaccine, 1998-05, Vol.16 (8), p.842-849

1998

Volltextzugriff (PDF)

Diagnosis of Oropouche Virus Infection Using a Recombinant Nucleocapsid Protein-Based Enzyme Immunoassay

Journal of Clinical Microbiology, 2001-07, Vol.39 (7), p.2445-2452

2001

Volltextzugriff (PDF)

Emerging zoonoses

Emerging infectious diseases, 1998-07, Vol.4 (3), p.453-454

1998

Volltextzugriff (PDF)

Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus

Virology (New York, N.Y.), 2003-08, Vol.313 (1), p.81-90

2003

Volltextzugriff (PDF)

Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing

Nucleic acids research, 2002-12, Vol.30 (23), p.e132-132

2002

Volltextzugriff (PDF)

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis

Virology (New York, N.Y.), 1992-03, Vol.187 (1), p.290-297

1992

Volltextzugriff (PDF)

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

Virology (New York, N.Y.), 1991-11, Vol.185 (1), p.401-410

1991

Volltextzugriff (PDF)

West Nile virus infection in nonhuman primate breeding colony, concurrent with human epidemic, southern Louisiana

Emerging infectious diseases, 2003-11, Vol.9 (11), p.1388-1394

2003

Volltextzugriff (PDF)

1 – 25 von 420

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(381)
Mit Volltextzugriff
(306)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(276)
Life Sciences & Biomedicine
(260)
Animals
(180)
Humans
(114)
Immunology
(78)
Medicine, Research & Experimental
(76)
Research & Experimental Medicine
(76)
Biological And Medical Sciences
(68)
Mice
(68)
Virology
(64)
Microbiology
(49)
Female
(48)
Old Medline
(45)
Infectious Diseases
(43)
Male
(43)
Neutralization Tests
(43)
Public, Environmental & Occupational Health
(40)
Fundamental And Applied Biological Sciences. Psychology
(39)
Medical Sciences
(38)
Tropical Medicine
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates

Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA

Antigenic Relationships between Flaviviruses as Determined by Cross-neutralization Tests with Polyclonal Antisera

Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America

Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever

Recurrence of Rift Valley fever in Egypt

Jatobal virus is a reassortant containing the small RNA of Oropouche virus

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains

Trocara virus: a newly recognized Alphavirus (Togaviridae) isolated from mosquitoes in the Amazon Basin

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial

Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature

Mayaro virus fever in French Guiana: isolation, identification, and seroprevalence

Mice immunized with a subviral particle containing the japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates

Diagnosis of Oropouche Virus Infection Using a Recombinant Nucleocapsid Protein-Based Enzyme Immunoassay

Emerging zoonoses

Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus

Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

West Nile virus infection in nonhuman primate breeding colony, concurrent with human epidemic, southern Louisiana

Suchergebnisse filtern